НовостиBenzingaGoldman Sachs Downgrades Bicara Therapeutics to Sell, Lowers Price Target to $8 Goldman Sachs Downgrades Bicara Therapeutics to Sell, Lowers Price Target to $8 Benzinga 2026.10.30 17:20 (GMT+0) Открыть на Benzinga Другие новости